Morgan Stanley Comera Life Sciences Holdings, Inc. Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.84 - $1.9 $2 - $5	-3 Reduced 0.13%	2,292 $2,000
Q4 2022 Feb 14, 2023	BUY	$1.2 - $1.93 $1 - $1	1 Added 0.04%	2,295 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.09 - $4.01 $0 - $8	2 Added 0.09%	2,294 $4,000
Q2 2022 Aug 15, 2022	BUY	$1.17 - $14.25 $2,681 - $32,661	2,292 New	2,292 $6,000

Ticker CMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,087,200
Description
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.